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Background: Over the last two decades, lifespan has increased significantly for people living 
with cystic fibrosis (CF). However, several studies have demonstrated that many young adults 
with CF report mental health problems and poor adherence to their prescribed treatments, 
challenging their long-term physical health. Treatment guidelines recommend interventions to 
improve adherence and self-management. The aim of this study was to test the feasibility of a 
life coaching intervention for young adults with CF.
Methods: A randomized, controlled feasibility study was conducted at the CF Center at 
Copenhagen University Hospital, Rigshospitalet. Participants were young adults with CF, aged 
18–30 years without severe intellectual impairments. Participants were randomized to either 
life coaching or standard care. The intervention consisted of up to 10 individual, face-to-face 
or telephone coaching sessions over a period of 1 year. Primary outcomes were recruitment 
success, acceptability, adherence to the intervention, and retention rates. Secondary outcome 
measures included health-related quality of life, adherence to treatment, self-efficacy, pulmonary 
function, body mass index, and blood glucose values.
Results: Among the 85 eligible patients approached, 40 (47%) were enrolled and randomized 
to the intervention or control group; two patients subsequently withdrew consent. Retention 
rates after 5 and 10 coaching sessions were 67% and 50%, respectively. Reasons for stopping 
the intervention included lack of time, poor health, perceiving coaching as not helpful, lack 
of motivation, and no need for further coaching. Coaching was primarily face-to-face (68%). 
No significant differences were found between the groups on any of the secondary outcomes.
Conclusion: Both telephone and face-to-face coaching were convenient for participants, with 
50% receiving the maximum offered coaching sessions. However, the dropout rate early in the 
intervention was a concern. In future studies, eligible participants should be screened for their 
interest and perceived need for support and life coaching before enrollment.
Keywords: life coaching, adherence, depression, quality of life, chronic disease
Background
Cystic fibrosis (CF) is a genetic, life shortening, multiorgan disease which primarily 
affects the pulmonary and digestive systems.1 Pulmonary exacerbations are the 
primary cause of increased morbidity and earlier mortality.2 However, optimization of 
medical treatment has improved lifespan, which is now projected to be over 50 years 
if mortality continues to decrease at the rate observed between 2000 and 2010.3 The 
treatment regimen includes daily preventive home treatments and intensified inpatient 
or outpatient treatments during pulmonary exacerbations.4 Despite inevitable declines in 
health and the challenges of managing CF on a daily basis, the majority of young adults 
with CF are either employed or enrolled in a college or university. However, many 
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young adults report elevated symptoms of depression and 
anxiety,5 poor adherence to prescribed treatments,6 and decre-
ments in health-related quality of life (HRQoL).7
Achieving an acceptable balance between taking 
responsibility for CF care and living a “normal” life, both 
professionally and socially, is a major challenge. Multiple 
barriers to adherence to treatment have been identified (ie, 
time constraints, competing priorities, and accidental and 
purposeful forgetting).8–10 Consensus reports have recom-
mended the development and evaluation of interventions to 
improve mental health, coping skills, and daily management 
of the disease.5,11
A systematic review of interventions aimed at improv-
ing adherence to prescribed CF medications found that 
even the most effective interventions did not lead to large 
improvements.12 Education and training in self-management 
(eg, life coaching) may be effective in facilitating patient 
adherence and management of daily stressors. Modest 
evidence suggests that self-management education has 
positive effects on these behavioral changes.13 Current 
evidence for the efficacy of psychological interventions for 
individuals with CF is limited. The most convincing results 
have been found for cognitive-behavioral interventions.14 
Motivational interviewing (MI), a patient-centered form 
of counseling which helps patients resolve ambivalence in 
regard to behavior change, is primarily designed to increase 
motivation and commitment to change.15 MI is most often 
used in combination with other programs and moderately 
efficacious results have been reported.16 Coaching interven-
tions overlap with the principles of MI, whereas the focus 
of MI is primarily on increasing motivation for specific 
behavior change, coaching is a whole-person model, 
which includes all life aspects.17 We hypothesized that a 
coaching intervention would empower young adults with 
CF to manage their treatment and daily functioning more 
effectively, thus improving health outcomes and HRQoL. 
Few studies have evaluated coaching interventions; thus, 
the primary aim of this study was to establish the feasibility 
of a coaching intervention for young adults with CF. 
Secondary aims included evaluating its effects on health 
outcomes and HRQoL.
Methods
Design
This feasibility study was a prospective, two-arm, random-
ized controlled trial comparing a life coaching interven-
tion to a control group receiving standard care at a Danish 
CF Center.
Patients and procedures
Study participants were recruited at the outpatient CF clinic 
at the Department of Infectious Diseases at Copenhagen 
University Hospital, Rigshospitalet, one of two hospitals in 
Denmark at which CF treatment is centralized. The depart-
ment treats ~200 adults with CF. All patients are scheduled 
to visit the outpatient clinic on a monthly basis. At these 
visits, the treating physicians (TP and TLK) or investigator 
and study coach (KBK) informed patients about the study. 
Patients who did not attend the sessions on a monthly basis 
received information about the study by letter; if there was 
no response, phone calls were made to determine the level 
of interest.
Eligible patients were between 18 and 30 years with a 
confirmed CF diagnosis by clinical findings, identification of 
two disease causing CFTR mutations, and a positive sweat 
chloride test. Exclusion criteria included severe intellectual 
impairment or insufficient mastery of the Danish language, 
determined by the inability to complete the questionnaires 
independently. After written informed consent, baseline 
data were collected and participants were randomized 1:1 in 
computer-generated blocks of four, to obtain equal numbers 
in both arms. We aimed to recruit 40 participants.
This study was conducted in accordance with the 
Declaration of Helsinki 2004 and all participants signed 
consent forms. This study was reviewed by the regional 
ethics committee of the Capital Region of Denmark and 
deemed exempt from a formal evaluation (H-2-2013-FSP01); 
it was registered at the Danish Data Protection Agency 
(j nr 30-0918) and at ClinicalTrials.gov (ID NCT02110914).
coaching intervention
All participants were given standard-of-care treatment and 
were randomized to either life coaching or the control con-
dition. All coaching sessions were delivered by one nurse 
(KBK) experienced with CF, certified by an Accredited 
Coaching Training Program, which included 125 student 
contact hours, 10 hours of mentor coaching, and a per-
formance evaluation.18 Participants allocated to coaching 
(coachees) were offered up to 10 individual coaching ses-
sions. The first and the last coaching sessions were intended 
to be face-to-face and last up to 90 minutes. Other coach-
ing sessions could be carried out either face-to-face or by 
telephone, according to participants’ preference, and lasted 
up to 60 minutes. Coaching sessions were scheduled every 
1–2 weeks early in the program and every 2–4 weeks later 
on. The entire coaching intervention was planned to last 
6–9 months. Coaching took place either in a quiet room at 
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the hospital outside the Department of Infectious Diseases 
or at a location close to the hospital.
The intervention was based on a life coaching model that 
was carried out in successive steps.19,20
1. The coach started by building a rapport and encouraging 
the coachee to tell his/her story.
2. The most important concern for the coachee was 
identified.
3. Goals were set by the coachee.
4. Barriers for achieving these goals were identified.
5. Collaborative action, consistent with the coachee’s 
values, was planned.
6. Progress was evaluated and new action plans and goals 
were negotiated.
The coaching intervention included the following 
elements: client-centeredness, empathy and collaboration, 
focus on preferences, reflective dialogue, use of positive 
language, and promotion of capacity and self-determination.21 
Sessions included different tools; for example, “the wheel of 
life”19 on which coachees could rate their level of satisfaction 
in different life areas. “Time management”22 was used to help 
participants structure and prioritize their time. Describing 
an ideal day or a dream for the future was integrated into 
the session to identify the participants’ values and short- 
and long-term goals. Finally, participants who reported 
symptoms of stress were guided to improve sleeping habits, 
engage in moderate physical exercise, and use mindfulness 
strategies, according to recommendations from The Danish 
Health Authority.23
Measurements
Primary study outcome
The primary outcome for this study was an evaluation of its 
feasibility. Feasibility measures were described by Bowen 
et al24 and included the following.
1. Acceptability: How individuals responded to the interven-
tion was assessed by analyzing dropout rates and reasons 
for dropout.
2. Demand: We assessed interest in this type of interven-
tion by comparing the recruitment rate with the number 
of eligible participants.
3. Practicality and implementation: Barriers and facilitators 
for implementation of the coaching intervention were 
evaluated by documenting the following variables in a 
logbook for each participant: total number of sessions, 
their frequency, duration of the coaching sessions, and 
mode of delivery (telephone or face-to-face). The content 
of the coaching sessions was confidential, but topics, 
process, and the use of different tools were also noted in 
the logbook.
4. Efficacy assessment: Intended effects of the coaching 
intervention were measured by patient-reported outcomes 
(PROs) and clinical parameters.
Demographic and disease information
Baseline demographic data were collected through question-
naires. Disease information was obtained through medical 
chart review and included CF mutations, body mass index 
(BMI), lung function, (forced expiratory volume in 1 second 
[FEV
1
]), glycated hemoglobin (HbA1C), chronic lung 
infection, and CF-related diabetes.
secondary study outcomes
The clinical parameters BMI, FEV
1
, and HbA1C, and PRO 
measures of adherence, depression, HRQoL, and self-efficacy 
were obtained as secondary outcome measures. The data 
collection took place at four time points (baseline), midway 
(after 5 months), post-intervention (after 11 months), and 
at follow-up (1 year post-intervention). Participants in 
the intervention group, who stopped after a few coaching 
sessions, completed the assessment at the same time points 
as the control group. Adherence was assessed by a validated, 
8-item questionnaire, the Morisky Medication Adherence 
Scale-8 item (MMAS-8).25–27 Adherence to the following 
treatments was assessed: dornase alfa inhalation, pancreatic 
enzymes, supplement vitamins (ADEK), inhaled antibiotic 
therapy, and positive expiratory pressure (PEP) therapy. 
To assess psychological well-being, two validated depres-
sion screening instruments were used: the Major Depression 
Inventory28 and Center for Epidemiologic Studies-Depression 
Scale.29 To assess HRQoL, the Cystic Fibrosis Questionnaire-
Revised-Teen/Adult version (CFQ-R)30 was completed; it 
is a validated, disease-specific HRQoL instrument for CF. 
The CFQ-R assesses demographic information (eg, age, 
education) and symptoms and functioning across 12 domains: 
Physical Functioning, Vitality, Emotional Functioning, Eat-
ing Disturbances, Treatment Burden, Health Perceptions, 
Social Functioning, Body Image, Role Functioning, Weight, 
Respiratory Symptoms, and Digestive Symptoms. Scores are 
standardized and range from 0 to 100, with higher scores indi-
cating better HRQoL. The Generalized Self-Efficacy scale,31 
a 10-item validated scale, measured self-efficacy beliefs.
statistical analyses
Baseline comparisons of demographic and disease charac-
teristics were performed by using an independent sample 
t-test for continuous variables and Fishers exact test for 
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categorical variables. Descriptive statistics (means and 
standard deviations [SDs]) were used to describe the sample. 
Data were analyzed using a two-way repeated measures 
analysis of variance (ANOVA) with a within-subject factor 
of time (baseline, midway, post-intervention, and follow-up) 
and a between-subject factor of group (coaching/control). 
Missing data were not imputed, and since ANOVA uses 
listwise deletion for missing data, the sample was reduced to 
18 participants (coaching group: n=7/control group: n=11). 
Mauchly’s test indicated that the assumption of sphericity 
had been violated; therefore, degrees of freedom were cor-
rected using Greenhouse–Geisser estimates of sphericity. 
A P-value ,0.05 was considered statistically significant. 
Effect size calculations were computed using partial eta 
squared (partial η2), whereby an effect size of 0.03 is con-
sidered small, 0.13 medium, and 0.26 large effects. This 
feasibility study was not powered to evaluate the efficacy of 
the intervention. All results should therefore be considered 
preliminary. Statistical analyses were performed using SPSS 
version 22 (SPSS Inc, IBM Corporation, Armonk, NY, USA).
Results
Participant characteristics
In total, 92 patients aged 18–30 years, with a confirmed 
diagnosis of CF, were eligible. Three patients were abroad 
and four patients were excluded due to cognitive impairment. 
Thus, 85 eligible adults were invited to participate. We con-
tinued to enroll individuals until we reached our intended 
number of 40 participants. This represented 47% of eligible 
participants at this adult CF Center. Fifteen young adults 
declined participation (18%) and 30 (35%) never responded. 
After randomization, two participants withdrew consent; 
thus, the final sample consisted of 38 participants (interven-
tion, n=18 and control, n=20; Figure 1). Demographic and 
baseline clinical characteristics are shown in Table 1. Most 
participants were female (71%), were employed or studying 
(87%), and half of the participants (50%) had average FEV
1
 
values above 70% of predicted. The intervention and the con-
trol group were comparable, but there were more participants 
with CF-related diabetes in the intervention group (44%) 
versus the control group (20%) and clinical parameters like 
FEV
1
, BMI, and HbA1C were slightly, but not significantly, 
worse in the intervention group.
Feasibility
Feasibility of the study was evaluated using data on accept-
ability, practicality and implementation, and limited efficacy 
testing.24
Acceptability
Acceptability was assessed using data on dropout rates and 
reasons for dropout. Retention rates after 5 and 10 coaching 
sessions were 67% and 50%, respectively. Reasons for stop-
ping the intervention included lack of time (n=1), poor health 
(n=1), coaching not being helpful (n=2), lack of motivation 
(n=1), no need for further coaching (n=2), and unknown 
reasons (n=2). Those who stopped because of “no need for 
further coaching” were not considered dropouts, as they had 
achieved what they wanted from the coaching intervention 
in ,10 sessions. Thus, the dropout rate overall was 39%.
Practicality and implementation
In total, 121 coaching sessions were performed. The majority 
of sessions were face-to-face sessions (n=82; 68%) and lasted 
on average 57 minutes (range 20–110). Thirty-nine coaching 
sessions were carried out by telephone (32%) and lasted on 
average 28 minutes (range 5–60). Telephone sessions were 
most often requested by participants who lived at a long 
distance from the hospital or who were feeling successful 
in implementing their action plans; they were primarily 
interested in having a call to evaluate their progress and, if 
necessary, adjust their plans. Telephone coaching was also 
used by participants to save time.
The number of same-day cancelations was 38 (31%); 
five (6 %) were no-shows. Planned telephone coaching 
calls were not answered 10 times (25%). Individuals who 
cancelled or were no-shows for in-person or telephone ses-
sions were offered new appointments. Due to the number of 
cancellations, it was not possible to adhere to the original 
schedule of intervals between coaching sessions. The time 
frame for completion of the coaching program varied; how-
ever, those who participated in all 10 sessions completed in 
8–15 months. The topics discussed in these sessions also 
varied across participants. The most frequently chosen topics 
were 1) work/study–life balance, 2) treatment adherence, 
3) stress reduction, 4) time management, 5) establishing 
priorities, and 6) improving eating or exercise habits. Many 
participants had difficulty in choosing a topic and setting 
goals at the first coaching session, but as evidenced by their 
satisfaction with different areas of life and their personal 
narrative, they were able to identify topics over time. A few 
(n=3) either never shared their concerns or stated they did 
not have any major life challenges.
secondary outcomes
Secondary outcomes included patient-reported measures of 
adherence, depression, HRQoL, and self-efficacy; furthermore, 
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the clinical parameters (FEV
1
, BMI, or HbA1C) were assessed. 
The means and SDs of all secondary outcomes for the 
coaching group and the control group over the four time 
points are presented in two tables; Table 2 shows outcomes of 
HRQoL and Table 3 shows all other secondary outcomes.
Adherence
Adherence was assessed using the MMAS-8 for dornase 
alfa, pancreatic enzymes, vitamin supplements (ADEK), 
inhaled antibiotic therapy, and PEP therapy. The scores 
on the MMAS-8 indicated that many participants (50%) 
????????????????????????????????????????????????????????????????????????????????????????????????
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Figure 1 Participant flow chart.
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Table 1 Baseline demographics and clinical characteristics
Total Intervention group Control group P-value
number 38 18 20
Age, mean (range) 23.7 (18–30) 23.6 (18–30) 23.7 (18–29) ns
Females, n (%) 27 (71) 12 (67) 15 (75) ns
BMi (kg/m2), mean (sD) 22.1 (3.8) 21.7 (3.9) 22.5 (3.9) ns
FeV1 % predicted, mean (sD) 73.4 (23) 71.3 (24.7) 75.5 (21.9) ns
FeV1 (#40%), n (%) 5 (13) 3 (17) 2 (10)
FeV1 (41%–70%), n (%) 14 (37) 7 (39) 7 (35)
FeV1 (.71%), n (%) 19 (50) 8 (44) 11 (55)
hbA1c%, mean (sD) 6.15 (1.50) 6.42 (1.69) 5.86 (1.23) ns
cFTr mutation classes 1 or 2 36 (95) 18 (100) 18 (90) ns
chronic pulmonary infection,a n (%) 21 (55) 10 (56) 11 (55) ns
cFrD, n (%) 12 (32) 8 (44) 4 (20) ns
single,b n (%) 19 (58) 10 (56) 9 (45) ns
lower education, n (%) 11 (29) 5 (28) 6 (30) ns
high school, n (%) 12 (32) 5 (28) 7 (35) ns
college/university, n (%) 15 (39) 8 (45) 7 (35) ns
employed or studying, n (%) 33 (87) 15 (83) 18 (90) ns
incapacitated to work/study, n (%) 3 (8) 2 (11) 1 (5) ns
Notes: aPseudomonas aeruginosa, Achromobacter xylosoxidans, and Burkholderia species. bSingle status is self-reported and defined as not having a romantic partner.
Abbreviations: FeV1, forced expiratory volume in 1 second; HbA1C, glycated hemoglobin; CFTR, cystic fibrosis transmembrane regulator protein; CFRD, cystic fibrosis-
related diabetes; NS, nonsignificant; SD, standard deviation; BMI, body mass index.
Table 2 Means and standard deviations of health-related quality of life scores from the cFQ-r at baseline, midway, post-intervention, 
and follow-up
Measured outcome Treatment Baseline Midway
(5 months)
Post-intervention
(11 months)
Follow-up (1 year 
post-intervention)
Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD) n
Physical Functioning coaching 75 (31.6) 18 74.4 (35.1) 13 81.9 (23.1) 9 68.2 (36.8) 12
control 80.2 (19.7) 20 76 (26) 17 80.3 (21) 18 78.5 (30.6) 12
role limitations coaching 82.5 (15.8) 18 80.6 (16.8) 12 78.1 (19.9) 8 81.1 (13.5) 11
control 77.9 (20.3) 20 73.4 (25.3) 17 83.8 (16.0) 18 87.9 (14.6) 11
Vitality coaching 46.8 (21.8) 18 51.8 (21) 13 49.1 (16.4) 9 46.5 (22.6) 12
control 48.5 (18.9) 20 50.8 (16.0) 17 63.9 (18.5) 18 57.2 (21.2) 12
emotional Functioning coaching 67.7 (19.2) 18 69.5 (20.7) 13 68.1 (17.2) 9 67.8 (21.6) 12
control 71 (21.2) 20 72.5 (17.1) 17 76.9 (11.3) 18 76.7 (19.2) 12
social Functioning coaching 67.9 (22.0) 18 72.2 (20.9) 13 67.9 (28.6) 9 67.1 (22.2) 12
control 70.7 (18.2) 20 70.7 (16.8) 17 75.9 (15.2) 18 70.8 (24.4) 12
Body image coaching 73.5 (25.3) 18 75.4 (18.6) 13 72.8 (26.1) 9 69.4 (25.6) 12
control 76.1 (25.8) 20 84.3 (20.1) 17 79.6 (21) 18 86.1 (15.8) 12
eating Disturbance coaching 89.5 (21.7) 18 88.9 (23.9) 13 90.1 (15.2) 9 93.5 (11.1) 12
control 89.4 (22.9) 20 88.2 (21.7) 17 90.4 (15.2) 18 86.1 (19.0) 12
Treatment Burden coaching 52.5 (20.8) 18 52.4 (24.8) 13 51.9 (18.4) 9 51.9 (16.6) 12
control 47.9 (21.9) 20 52.3 (22.5) 17 56.8 (22.2) 18 57.4 (25.4) 12
health Perception coaching 58.6 (25.5) 18 57.9 (29) 13 51.9 (26.1) 9 48.1 (26.1) 12
control 58.3 (24.9) 20 56.9 (20) 17 60.5 (23.9) 18 58.3 (29.3) 12
Weight Problems coaching 77.8 (37.9) 18 88.1 (28.1) 13 77.8 (33.3) 9 80.6 (26.4) 12
control 83.3 (36.7) 20 80.4 (35.5) 17 83.3 (30.8) 18 80.6 (38.8) 12
respiratory symptoms coaching 65.6 (19.6) 18 61.5 (18.7) 13 60.5 (16.5) 9 60.2 (23.9) 12
control 67.2 (25) 20 73.3 (21.6) 17 70.1 (22.6) 18 70.8 (20.3) 12
Digestive symptoms coaching 74.1 (25.2) 18 65.9 (20.7) 13 67.9 (23.9) 9 61.1 (23.5) 12
control 71.1 (27.1) 20 81.3 (15.0) 16 75.7 (18.7) 16 73.7 (25.5) 11
Abbreviations: sD, standard deviation; cFQ-r, cystic Fibrosis Questionnaire revised version.
were poorly adherent to pancreatic enzymes and inhaled 
antibiotics. However, even worse adherence was reported 
for PEP treatments and dornase alpha (74% not adher-
ing) (Table 4). Repeated measures ANOVA showed no 
significant result for any of the adherence outcomes; a 
medium effect size was found for dornase alpha over time 
(partial η2=0.137) and for PEP over time (partial η2=0.186) 
(Table 5).
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Depression
More than one-quarter of patients endorsed elevated symp-
toms of depression (26.2%) (Table 4). There were no differ-
ences between the groups over time (Table 5).
hrQol
At baseline, CFQ-R scores were the lowest (worst) in both 
groups for Vitality and Treatment Burden and were highest 
(best) for Eating Disturbances, Weight Problems, and Role 
Table 3 Means and standard deviations of secondary outcomes at baseline, midway, post-intervention, and follow-up
Measured outcome Treatment Baseline Midway
(5 months)
Post-intervention
(11 months)
Follow-up (1 year 
post-intervention)
Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD) n
Dornase alfaa coaching 4.25 (2.43) 16 4.45 (2.44) 13 4.67 (2.37) 9 4.70 (1.87) 11
control 3.86 (2.73) 18 3.72 (2.33) 15 3.53 (2.67) 15 2.98 (1.77) 10
Pancreatic enzymesa coaching 5.11 (2.19) 18 4.88 (1.95) 12 5.53 (1.99) 9 5.23 (2.15) 12
control 6.08 (1.56) 18 5.88 (1.66) 17 6.32 (1.49) 17 5.39 (2.12) 11
Vitamins supplementa coaching 5.14 (2.56) 18 5.13 (2.19) 13 5.94 (2.06) 9 5.04 (2.30) 12
control 4.93 (2.56) 20 5.24 (2.70) 17 5.69 (2.51) 18 5.69 (2.51) 11
inhaled antibioticsa coaching 4.50 (2.45) 14 4.52 (2.45) 13 4.97 (2.47) 8 4.40 (2.46) 8
control 5.04 (2.54) 18 5.03 (2.48) 16 5.30 (2.31) 15 4.39 (2.32) 11
PePa coaching 3.81 (2.66) 16 3.92 (2.84) 13 4.17 (2.50) 9 3.79 (2.55) 12
control 3.62 (2.96) 19 3.36 (2.55) 16 3.36 (2.76) 16 2.78 (1.34) 10
gse coaching 32.1 (5.71) 18 33.2 (5.27) 13 32.9 (6.58) 9 30.4 (6.44) 11
control 32.9 (4.12) 20 34.1 (4.63) 16 34.9 (4.39) 18 34.6 (4.32) 11
MDi coaching 13.6 (7.82) 18 13.4 (11.2) 13 11.9 (7.03) 9 12.9 (8.67) 12
control 13.3 (10.7) 20 10.9 (6.95) 17 9.18 (6.00) 17 10.9 (9.76) 12
ces-D coaching 7.89 (10.8) 18 11.3 (11.4) 13 9.71 (7.11) 7 13.3 (10.3) 12
control 9.10 (9.85) 20 12.5 (8.94) 16 10.1 (8.51) 18 12.8 (10.8) 12
FeV1 coaching 71.3 (24.7) 18 74.4 (27.9) 18 69.9 (25.3) 18 71.0 (23.0) 17
control 75.5 (21.9) 20 73.9 (22.5) 20 73.5 (19.2) 19 75.2 (23.2) 19
BMi coaching 21.7 (3.91) 18 22.5 (4.59) 18 22.0 (4.23) 18 22.2 (3.78) 17
control 22.5 (3.93) 20 22.7 (4.06) 20 22.1 (3.48) 19 23.2 (4.53) 19
hbA1c coaching 6.41 (1.69) 17 5.99 (2.31) 14 6.65 (1.76) 13 6.31 (1.53) 16
control 5.86 (1.24) 16 6.11 (1.13) 14 5.96 (1.31) 10 5.96 (0.87) 19
Notes: ascores accessed by MMAs-8. The MMAs (8-item) content, names and trademarks are protected by Us copyright and trademark laws. Permission for use of the scale 
and its coding is required. A license agreement is available from: Donald e. Morisky, scD, scM, MsPh,14725 ne 20th st Bellevue, WA 98007, UsA; dmorisky@gmail.com. 
Abbreviations: SD, standard deviation; MMAS-8, Morisky Medication Adherence Scale-8; PEP, positive expiratory pressure; GSE, General Self-Efficacy; MDI, Major Depres sion 
inventory; ces-D, center for epidemiologic studies-Depression scale; FeV1, forced expiratory volume in 1 second; BMi, body mass index; hbA1c, glycated hemoglobin.
Table 4 Baseline and post-intervention distribution of adherence and depression scores
Baseline Post-intervention 
(11 months)
Follow-up (1 year 
post-intervention)
Total 
group
(n=38)
Coaching 
group 
(n=18)
Control 
group
 (n=20)
Coaching 
group
(n=9)
Control 
group
(n=18)
Coaching 
group
(n=12)
Control 
group
(n=12)
% % % % % % % 
Dornase alfa
low adherencea
76% 75% 78% 67% 80% 72% 90% 
Pancreatic enzymes
low adherencea
50% 67% 33% 67% 41% 67% 55% 
Vitamine supplements
low adherencea
58% 56% 60% 56% 39% 67% 64% 
inhaled antibiotics
low adherencea
56% 64% 50% 63% 53% 64% 64% 
PeP
low adherencea
74% 75% 74% 78% 75% 83% 100% 
MDi
Mild depression
15.7% 17% 15% 22% 0 8.3% 8.3% 
MDi
Moderate depression
2.6% 0 5% 0 5.6% 0 17% 
MDi
severe depression 
7.9% 5.6% 10% 0 0 8.3% 0
ces-D depressionb 26% 22% 30% 22% 22% 25% 25% 
Notes: alow adherence: Morisky Medication Adherence scale-8 item scores ,6. bDepression: ces-D scores .16.
Abbreviations: PeP, positive expiratory pressure; MDi, Major Depression inventory; ces-D, center for epidemiologic studies-Depression scale.
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Functioning (Table 2). There was no significant difference 
in any of the CFR-Q outcomes; however, an improvement in 
the CFQ-R Vitality in the control group gave a large effect 
size (partial η2=0.303) (Table 5).
Self-efficacy
The mean self-efficacy score was 33.5 (SD 5.2) of a total 
score of 40. There were no differences between the groups 
over time (Table 5).
No significant improvements in the PRO measures were 
observed in the coaching group. In addition, no significant 
improvements were detected in patients’ clinical parameters 
(FEV
1
, BMI, or HbA1C) (Table 5). Neither within nor between 
group differences emerged in these outcome measures.
Discussion
In this study, we evaluated the feasibility of a life coaching 
intervention for young adults with CF. Using a random-
ized controlled design, we found that 50% of participants 
allocated to the intervention group attended the maximum 
offered coaching sessions, and both face-to-face and tele-
phone coaching were rated as convenient for participants. 
This study successfully recruited the desired number of 
consenting participants, which was set a priori (n=40). 
This represented 47% of our clinic sample of eligible 
young adults with CF. A systematic review of lifestyle 
interventions reported recruitment rates ranging from 7% 
to 28%;32 thus, recruitment of our target sample, which 
represented half of our adult clinic population, indicated 
significant interest in and willingness to participate in a 
coaching intervention.
Comparing our baseline data with a recent cross-sectional 
study suggested that our study population was representative 
of the larger Danish CF adult population in relation to age, 
disease severity, and educational level.7 One key observation 
was that our participants were primarily female, representing 
71% of our sample. It is possible that a coaching intervention 
is more appealing to women than men; furthermore, given 
that the coach was also female, this might also have influ-
enced the gender distribution. Baseline self-efficacy scores 
Table 5 The main effects between the intervention group and the control group over time (baseline, midway, post-intervention, and 
follow-up) on secondary outcomes
Measured outcomes Factor P-value Partial η2 Measured outcomes Factor P-value Partial η2
Physical Functioningc Timea 0.10 0.132 Dornase alphad Time 0.17 0.137
groupb 0.73 0.008 group 0.62 0.210
role limitationsc Time 0.41 0.058 Pancreatic enzymesd Time 0.20 0.103
group 0.59 0.021 group 0.68 0.012
Vitalityc Time 0.16 0.303 Vitamins supplementd Time 0.55 0.046
group 0.31 0.064 group 0.44 0.044
emotional Functioningc Time 0.36 0.063 inhaled antibioticsd Time 0.79 0.024
group 0.52 0.027 group 0.95 0.001
social Functioningc Time 0.67 0.138 PePd Time 0.08 0.186
group 0.91 0.001 group 0.32 0.076
Body imagec Time 0.74 0.047 gse Time 0.31 0.094
group 0.26 0.078 group 0.71 0.012
eating Disturbancec Time 0.43 0.049 MDi Time 0.15 0.112
group 0.61 0.017 group 0.35 0.059
Treatment Burdenc Time 0.62 0.034 ces-D Time 0.15 0.114
group 0.84 0.003 group 0.94 0.00
health Perceptionc Time 0.03 0.177 FeV1 Time 0.40 0.035
group 0.36 0.053 group 0.91 0.001
Weight Problemsc Time 0.73 0.020 BMi Time 0.73 0.007
group 0.91 0.001 group 0.62 0.012
respiratory symptomsc Time 0.18 0.096 hbA1c Time 0.17 0.226
group 0.07 0.197 group 0.56 0.051
Digestive symptomsc Time 0.69 0.032
group 0.68 0.013
Notes: Data were analyzed using a two-way repeated AnOVA. aWithin-subject factors: repeated time measures (baseline, midway, post-intervention, and follow-up). 
bBetween-subject factors: coaching group (n=7)/control group (n=11). cscores assessed by cFQ-r. dscores assessed by MMAs-8.
Abbreviations: cFQ-r, cystic Fibrosis Questionnaire revised version; MMAs-8, Morisky Medication Adherence scale-8; PeP, positive expiratory pressure; gse, general 
Self-Efficacy; MDI, Major Depression Inventory; CES-D, Center for Epidemiologic Studies-Depression Scale; FEV1, forced expiratory volume in 1 second; BMi, body mass 
index; hbA1c, glycated hemoglobin; AnOVA, analysis of variance.
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(mean (SD) 33.5 (5.2)) were higher than the scores among a 
group of German high school students (mean (SD) 29.6 (4.0)) 
(n=3,494).33 Self-efficacy is a measurement of an individual’s 
belief in his or her ability to master a given task; thus, the 
high self-efficacy score could indicate that this group of 
participants already had good problem solving skills, when 
they entered the study.
Rates of attrition were 39% in the coaching group. Attri-
tion rates as high as 18%–26% are not unusual in studies 
of counseling interventions.34,35 Dropout rates in previous 
studies have been associated with symptoms of depres-
sion, e-therapy (mental health services over the Internet), 
outpatient settings, and interventions that include a large 
number of sessions.35 High dropout rates have also been 
found in studies targeting behavior change using personal 
goal setting and identification of barriers.34 Many of the chal-
lenges associated with high dropout rates also occurred in 
our intervention. Thus, when designing coaching and other 
counseling interventions, high rates of attrition should be 
expected and studies should be powered to assess efficacy 
taking this dropout rate into account. Strategies that minimize 
attrition (eg, excluding those that endorse severe depression; 
offering fewer sessions) should be considered.
We used life coaching as a method for supporting young 
adults with CF to improve their HRQoL and self-efficacy 
and to assist them in overcoming barriers to good CF care. 
All coaching sessions were carried out by a single certified 
coach, which ensured consistency across participants and 
sessions. The intervention followed a general model for life 
coaching;19,20 however, since coaching sessions were indi-
vidualized, the approach was tailored to the specific needs 
of each participant.
We found that both face-to-face and telephone coaching 
appealed to participants. Participants preferred face-to-face 
coaching, but the opportunity to have telephone coaching 
was useful for those who lived far away or wanted to save 
time. Telephone coaching was also used to evaluate progress 
in completing action plans. Face-to-face versus telephone 
coaching has been evaluated in a few studies with ambigu-
ous results: one study found both methods to be effective,36 
but another found that face-to-face sessions were superior to 
telephone coaching.37 Our study did not compare the effec-
tiveness of these two methods. Thus, we cannot recommend 
one method over another. We did, however, find that patients 
appreciated having both options available.
Participants discussed a variety of topics (eg, work/
study–life balance, treatment adherence, stress reduction, 
time management, establishing priorities, and improvement 
of eating or exercise habits). Similar themes have been 
documented in several studies, indicating that issues related 
to time management, treatment burden, and adherence are 
critical challenges for adults with CF.8–10 This also converged 
with our data on self-reported adherence. Poor adherence was 
reported by 50%–76% of study participants and this topic 
was frequently addressed in the coaching sessions. We did 
not find an association between our intervention and rates 
of adherence, but the study was not powered to evaluate the 
efficacy of the intervention.
Stress reduction was also an important topic and this often 
involved establishing priorities, achieving a better work–life 
balance, and managing time more effectively. A recent study 
among young adults with CF found that 52% of their study 
population felt that CF had a negative impact on education, 
employment, and other life situations, and the authors state 
that there is a need for additional support in these issues.38 The 
individual’s response to stress can increase vulnerability to 
depression especially if persistent stress is not resolved through 
emotion or problem-solved coping or adaption.39 It would have 
been an advantage for our study if we had also included measur-
ing tools to evaluate perceived stress and coping strategies.
The interval between coaching sessions and total length 
of the coaching program was prolonged due to frequent 
cancellations. There are no clear recommendations on how 
frequently coaching sessions should be scheduled, but one of 
the basic principles of coaching is that the coachees commit 
themselves to an action plan, with coaching sessions facili-
tating accountability for these plans.19 The risk of relapse 
during these stages of change may increase if the gap between 
coaching sessions is too wide.
limitations
Although this study is the first to explore the feasibility of a 
coaching intervention for young adults with CF, it had limita-
tions. First, participants were not initially screened for their 
need or interest in a coaching intervention. This may have 
influenced their level of commitment to the intervention, 
especially for those who did not perceive a need for it. This 
may have also influenced both cancellations of appointments 
and dropout rates. Future studies should evaluate interest 
and level of motivation for participating in a life coaching 
session. Second, even though this was a feasibility study, 
which by its nature lacked power to detect any differences, 
the high dropout rates for the intervention group could have 
a negative impact of the random assignment; especially 
concerning are the low response rates for the questionnaires 
among participants who dropped out. Third, this intervention 
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may not be appropriate for those with severe depressive 
symptoms. Future studies should consider screening out 
those who express this degree of depressive symptomatol-
ogy. It is likely that they need a different type of intervention, 
delivered in a more intensive way. Fourth, to learn more 
about the individual life stressors and the strategies used to 
overcome barriers to manage stress in a life with CF, future 
studies should consider including instruments to measure 
perceived stress and coping strategies.
Conclusion
Young adults with CF were willing to participate in a life 
coaching intervention, and almost half of the participants 
attended the maximum number of offered coaching ses-
sions. The issues participants chose to work on were related 
to study/work–life balance, barriers to treatment adherence, 
and stress. Participants preferred face-to-face coaching, but 
they also utilized telephone-based counseling when needed. 
The relatively high dropout rate early in the intervention was 
a concern. In future studies, participants should be screened 
for their interest in this type of intervention and those 
with severely elevated symptoms of depression should be 
excluded. A study using coaching to reduce stress symptoms 
among patients with CF should be considered.
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